bluebird bio (BLUE) to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual Congress
Go back to bluebird bio (BLUE) to Present Data from Its Severe Genetic Disease and Oncology Portfolios During the EHA2021 Virtual CongressBLUEBIRD BIO (NASDAQ: BLUE) | Delayed: 0.95 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.95 | 52 Week High | $95.28 | |||
Open | $0.95 | 52 Week Low | $35.37 | |||
Day High | $0.95 | P/E | N/A | |||
Day Low | $0.95 | EPS | $-1.81 | |||
Volume | 300 |